Serum CCL11 level is associated with radiographic spinal damage in patients with ankylosing spondylitis
- 157 Downloads
The clinical significance of C–C motif chemokine11 (CCL11) in bone metabolism in ankylosing spondylitis (AS) is not clearly elucidated. Thus, this cross-sectional study aimed to compare serum levels of CCL11 between patients with AS and healthy controls and to investigate the relationship between serum levels of CCL11 and radiographic spinal damage in patients with AS. We consecutively recruited 55 male patients with AS and 26 age- and sex-matched healthy controls. Serum levels of CCL11, tumor necrosis factor-α (TNF-α), interleukin-17, and Dickkopf-1 (DKK-1) were measured with commercially available enzyme-linked immunosorbent assay kits. Radiographs were scored according to the modified Stoke ankylosing spondylitis spine score (mSASSS), and syndesmophytes were defined as mSASSS ≥ 2. The serum levels of CCL11 in AS patients with syndesmophytes were significantly higher than those in AS patients without syndesmophytes (p = 0.007) and healthy controls (p = 0.006). In AS patients, the serum levels of CCL11 were significantly and positively correlated with mSASSS (p = 0.006), number of syndesmophytes (p = 0.029). After adjusting for confounding factors, elevated serum levels of CCL11 were associated with increased mSASSS (β = 0.007, p = 0.03) and higher risk for the presence of syndesmophytes (OR 2.34 per 50 pg/ml increase, p = 0.012) in AS patients. We found that the serum level of CCL11 was associated with structural damage in patients with AS, suggesting that CCL11 may serve as a promising biomarker for new bone formation in AS.
KeywordsAnkylosing spondylitis CC chemokines Osteogenesis Biomarkers Tumor necrosis factor
We specially thank the late Professor Sung-Il Kim who devoted himself to education, research, and patient care in Division of Rheumatology, Department of Internal Medicine, Pusan National University School of Medicine (1963 to 2011).
DHS: research concept and study design, performance of the tests, statistical analysis, data analysis and interpretation, and drafting the article; HJ: performance of the tests and data analysis; JSR: performance of the tests and data analysis; HNL: radiographic data analysis; EK: clinical examination, sample collection and data acquisition; JHK: data interpretation; SGL: research concept and study design, study subject recruitment, statistical analysis, data analysis and interpretation, and drafting the article, manuscript editing, substantial supervision and coordination of the study. All authors approved the final version of the paper.
This work was supported by the research fund of Rheumatology Research Foundation (RRF-2017-01). Also, this research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2016R1D1A1B03934716).
Compliance with ethical standards
Conflict of interest
The authors have declared no conflict of interest.
The present study was approved by the Research and Ethical Review Board of Pusan National University Hospital (IRB No. 1603-005-039). All study participants provided written informed consent in accordance with the principles of the Declaration of Helsinki.
- 2.Park EK, Pak K, Park JH, Kim K, Kim SJ, Kim IJ, Kim GT, Lee SG (2017) Baseline increased 18F-fluoride uptake lesions at vertebral corners on positron emission tomography predict new syndesmophyte development in ankylosing spondylitis: a 2-year longitudinal study. Rheumatol Int 37(5):765–773. https://doi.org/10.1007/s00296-017-3660-2 CrossRefPubMedGoogle Scholar
- 6.Sakellariou GT, Iliopoulos A, Konsta M, Kenanidis E, Potoupnis M, Tsiridis E, Gavana E, Sayegh FE (2017) Serum levels of Dkk-1, sclerostin and VEGF in patients with ankylosing spondylitis and their association with smoking, and clinical, inflammatory and radiographic parameters. Joint Bone Spine 84(3):309–315. https://doi.org/10.1016/j.jbspin.2016.05.008 CrossRefPubMedGoogle Scholar
- 7.Korkosz M, Gasowski J, Leszczynski P, Pawlak-Bus K, Jeka S, Kucharska E, Grodzicki T (2013) High disease activity in ankylosing spondylitis is associated with increased serum sclerostin level and decreased wingless protein-3a signaling but is not linked with greater structural damage. BMC Musculoskelet Disord 14:99. https://doi.org/10.1186/1471-2474-14-99 CrossRefPubMedPubMedCentralGoogle Scholar
- 9.Syrbe U, Callhoff J, Conrad K, Poddubnyy D, Haibel H, Junker S, Frommer KW, Muller-Ladner U, Neumann E, Sieper J (2015) Serum adipokine levels in patients with ankylosing spondylitis and their relationship to clinical parameters and radiographic spinal progression. Arthritis Rheumatol 67(3):678–685. https://doi.org/10.1002/art.38968 CrossRefPubMedGoogle Scholar
- 10.Park JH, Lee SG, Jeon YK, Park EK, Suh YS, Kim HO (2017) Relationship between serum adipokine levels and radiographic progression in patients with ankylosing spondylitis: a preliminary 2-year longitudinal study. Medicine (Baltimore) 96(33):e7854. https://doi.org/10.1097/MD.0000000000007854 CrossRefGoogle Scholar
- 15.Paplinska M, Hermanowicz-Salamon J, Nejman-Gryz P, Bialek-Gosk K, Rubinsztajn R, Arcimowicz M, Placha G, Gora J, Chazan R, Grubek-Jaworska H (2012) Expression of eotaxins in the material from nasal brushing in asthma, allergic rhinitis and COPD patients. Cytokine 60(2):393–399. https://doi.org/10.1016/j.cyto.2012.07.001 CrossRefPubMedGoogle Scholar
- 18.Hueber W, Tomooka BH, Zhao X, Kidd BA, Drijfhout JW, Fries JF, van Venrooij WJ, Metzger AL, Genovese MC, Robinson WH (2007) Proteomic analysis of secreted proteins in early rheumatoid arthritis: anti-citrulline autoreactivity is associated with up regulation of proinflammatory cytokines. Ann Rheum Dis 66(6):712–719. https://doi.org/10.1136/ard.2006.054924 CrossRefPubMedGoogle Scholar
- 19.Syversen SW, Goll GL, Haavardsholm EA, Boyesen P, Lea T, Kvien TK (2008) A high serum level of eotaxin (CCL 11) is associated with less radiographic progression in early rheumatoid arthritis patients. Arthritis Res Ther 10(2):R28. https://doi.org/10.1186/ar2381 CrossRefPubMedPubMedCentralGoogle Scholar
- 21.van der Heijde D, Lie E, Kvien TK, Sieper J, Van den Bosch F, Listing J, Braun J, Landewe R (2009) ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis. Ann Rheum Dis 68(12):1811–1818. https://doi.org/10.1136/ard.2008.100826 CrossRefPubMedGoogle Scholar
- 24.Papaioannou A, Morin S, Cheung AM, Atkinson S, Brown JP, Feldman S, Hanley DA, Hodsman A, Jamal SA, Kaiser SM, Kvern B, Siminoski K, Leslie WD, Osteoporosis SAC (2010) 2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary. Can Med Assoc J 182(17):1864–1873. https://doi.org/10.1503/cmaj.100771 CrossRefGoogle Scholar
- 25.Compston J, Bowring C, Cooper A, Cooper C, Davies C, Francis R, Kanis JA, Marsh D, McCloskey EV, Reid DM, Selby P (2013) Diagnosis and management of osteoporosis in postmenopausal women and older men in the UK: National Osteoporosis Guideline Group (NOGG) update 2013 (vol 75, pg 392, 2013). Maturitas 76(4):387–387. https://doi.org/10.1016/j.maturitas.2013.08.006 CrossRefGoogle Scholar
- 28.Diarra D, Stolina M, Polzer K, Zwerina J, Ominsky MS, Dwyer D, Korb A, Smolen J, Hoffmann M, Scheinecker C, van der Heide D, Landewe R, Lacey D, Richards WG, Schett G (2007) Dickkopf-1 is a master regulator of joint remodeling. Nat Med 13(2):156–163. https://doi.org/10.1038/nm1538 CrossRefPubMedGoogle Scholar
- 29.Li J, Sarosi I, Cattley RC, Pretorius J, Asuncion F, Grisanti M, Morony S, Adamu S, Geng Z, Qiu W, Kostenuik P, Lacey DL, Simonet WS, Bolon B, Qian X, Shalhoub V, Ominsky MS, Zhu Ke H, Li X, Richards WG (2006) Dkk1-mediated inhibition of Wnt signaling in bone results in osteopenia. Bone 39(4):754–766. https://doi.org/10.1016/j.bone.2006.03.017 CrossRefPubMedGoogle Scholar
- 34.Arends S, Spoorenberg A, Efde M, Bos R, Leijsma MK, Bootsma H, Veeger NJ, Brouwer E, van der Veer E (2014) Higher bone turnover is related to spinal radiographic damage and low bone mineral density in ankylosing spondylitis patients with active disease: a cross-sectional analysis. PLoS ONE 9(6):e99685. https://doi.org/10.1371/journal.pone.0099685 CrossRefPubMedPubMedCentralGoogle Scholar
- 39.Hong S, Lee EE, Martin AS, Soontornniyomkij B, Soontornniyomkij V, Achim CL, Reuter C, Irwin MR, Eyler LT, Jeste DV (2017) Abnormalities in chemokine levels in schizophrenia and their clinical correlates. Schizophr Res 181:63–69. https://doi.org/10.1016/j.schres.2016.09.019 CrossRefPubMedGoogle Scholar
- 40.Magalhaes PV, Jansen K, Stertz L, Ferrari P, Pinheiro RT, da Silva RA, Kapczinski F (2014) Peripheral eotaxin-1 (CCL11) levels and mood disorder diagnosis in a population-based sample of young adults. J Psychiatr Res 48(1):13–15. https://doi.org/10.1016/j.jpsychires.2013.10.007 CrossRefPubMedGoogle Scholar